Both in Biotechnology
Gilead Sciences vs Moderna
Over the past year GILD returned +35.2% and MRNA returned +678.8%; their daily moves had a correlation of 0.23.
GILD +35.2% MRNA +678.8%Growth of $1, one year, split-adjusted
| Metric | GILD | MRNA |
|---|---|---|
| Price | $152.21 | $197.28 |
| Market cap | $188.73B | $78.76B |
| Today | +0.85% | −0.80% |
| 1 month | +2.3% | +38.2% |
| 6 months | +13.4% | +298.1% |
| Year to date | +24.0% | +569.0% |
| 1 year | +37.1% | +701.6% |
| Revenue growth (YoY) | +10.2% | +2.1% |
| Gross margin | 79.8% | 35.9% |
| Net margin | −134.5% | −539.3% |
| P/E (TTM) | — | — |
| Price / sales | 6.2× | 35.4× |
| Net cash | -$23.07B | $4.54B |
| Dividend yield | 2.15% | — |
| Volatility (60d) | 27.0% | 227.6% |
| Short % of float | 1.5% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).